• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by CVS Health Corporation

    4/3/26 4:05:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $CVS alert in real time by email
    DEFA14A 1 cvs014969-defa14a.htm DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS CVS HEALTH CORPORATION DEFA 14A

    UNITED STATES

     

    SECURITIES AND EXCHANGE COMMISSION

     

    Washington, DC 20549

     

    SCHEDULE 14A

     

    PROXY STATEMENT PURSUANT TO SECTION 14(a)
    OF THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No.     )

     

      Filed by the Registrant   Filed by a Party other than the Registrant

     

    Check the appropriate box:
    Preliminary Proxy Statement
    Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(E)(2))
    Definitive Proxy Statement
    Definitive Additional Materials
    Soliciting Material under ss.240.14a-12

     

    CVS Health Corporation

     

     

    (Name of Registrant as Specified in Its Charter)

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check all boxes that apply):
    No fee required.
    Fee paid previously with preliminary materials.
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
     

     

          Your Vote Counts!  
          CVS HEALTH CORPORATION  
     

     

    CVS HEALTH CORPORATION
    C/O EQUINITI SHAREOWNER SERVICES
    P.O. BOX 64945
    ST. PAUL, MN 55164-0945

     

    2026 Annual Meeting

    May 14, 2026 at 8:00 A.M., ET
    www.virtualshareholdermeeting.com/CVS2026

    Vote by May 13, 2026 at 11:59 P.M., ET

     
           
           
           
             
             
             
             
             
             
      V88956-P47890

         
           

     

    You invested in CVS HEALTH CORPORATION and it’s time to vote!

    You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the Annual Meeting of Stockholders to be held on May 14, 2026.

     

    Get informed before you vote

    View the Notice of 2026 Annual Meeting of Stockholders and Proxy Statement and the 2025 Annual Report to Stockholders online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 30, 2026. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

     

         
    For complete information and to vote, visit www.ProxyVote.com
    Control #
         

     

    Smartphone users

     

    Point your camera here and
    vote without entering a
    control number

       

    We urge you to vote in advance, but you may also vote virtually at the Annual Meeting*

     

    May 14, 2026
    8:00 A.M., ET

     

     

    Virtually at:
    www.virtualshareholdermeeting.com/CVS2026

           

     

    * Please check the meeting materials for any special requirements for meeting attendance.
     
    Vote at www.ProxyVote.com  

     

    THIS IS NOT A VOTABLE BALLOT

     

     

    This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

           

     

    Voting Items Board
    Recommends
    1. Election of Directors  
      Nominees:              
    1a. Fernando Aguirre  For
    1b. Jeffrey R. Balser, M.D., Ph.D.  For
    1c. C. David Brown II  For
    1d. Alecia A. DeCoudreaux  For
    1e. Anne M. Finucane  For
    1f. John E. Gallina  For
    1g. J. David Joyner  For
    1h. J. Scott Kirby  For
    1i. Michael F. Mahoney  For
    1j. Leslie V. Norwalk  For
    1k. Larry M. Robbins  For
    1l. Guy P. Sansone  For
    1m. Douglas H. Shulman  For
    2. Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026.  For
    3.

    Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company’s Executive Compensation.

     For
    4. Proposal to Approve the Company’s 2026 Incentive Compensation Plan.  For
    5. Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent.  Against
    NOTE: In their discretion, the proxies may vote on such other business as may properly come before the meeting or any adjournment thereof.  
       
       
       
       
    Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.
     
    V88957-P47890
     
    Get the next $CVS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS

    DatePrice TargetRatingAnalyst
    3/12/2026$94.00Mkt Perform → Outperform
    Bernstein
    10/14/2025$91.00Buy
    Goldman
    8/18/2025$79.00Neutral → Buy
    UBS
    8/14/2025$82.00Neutral → Outperform
    Robert W. Baird
    2/13/2025$55.00 → $75.00Market Perform → Outperform
    Leerink Partners
    2/12/2025Neutral → Overweight
    Cantor Fitzgerald
    1/30/2025Hold → Buy
    Edward Jones
    12/3/2024$66.00Hold → Buy
    Deutsche Bank
    More analyst ratings

    $CVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Cont & Chief Acct Officer Clark James David covered exercise/tax liability with 454 shares, decreasing direct ownership by 2% to 27,606 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/29/26 3:11:55 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP, Chief Financial Officer Newman Brian covered exercise/tax liability with 2,478 shares, decreasing direct ownership by 45% to 3,008 units (SEC Form 4) (withholding obligation)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/1/26 5:02:36 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP, Chief Medical Officer Compton-Phillips Amy covered exercise/tax liability with 7,618 shares, decreasing direct ownership by 44% to 9,557 units (SEC Form 4) (tax withholding)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/1/26 5:00:41 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CVS Health upgraded by Bernstein with a new price target

    Bernstein upgraded CVS Health from Mkt Perform to Outperform and set a new price target of $94.00

    3/12/26 8:38:26 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Goldman initiated coverage on CVS Health with a new price target

    Goldman initiated coverage of CVS Health with a rating of Buy and set a new price target of $91.00

    10/14/25 8:48:20 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health upgraded by UBS with a new price target

    UBS upgraded CVS Health from Neutral to Buy and set a new price target of $79.00

    8/18/25 8:45:28 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and President, Aetna Nelson Steven H bought $1,289 worth of shares (24 units at $53.70) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    1/27/26 5:20:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    SEC Filings

    View All

    SEC Form 11-K filed by CVS Health Corporation

    11-K - CVS HEALTH Corp (0000064803) (Filer)

    6/23/26 4:59:46 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form S-8 filed by CVS Health Corporation

    S-8 - CVS HEALTH Corp (0000064803) (Filer)

    5/22/26 4:28:36 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form S-3ASR filed by CVS Health Corporation

    S-3ASR - CVS HEALTH Corp (0000064803) (Filer)

    5/22/26 4:27:23 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CVS Health Helping to Strengthen Communities Across Massachusetts

    The company's community health investments are expanding access to housing, care and essential resources across the CommonwealthWOONSOCKET, R.I., July 22, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) today highlighted its continued investments in improving the health of communities across Massachusetts, spanning affordable housing, collaborations with local nonprofit organizations and free health services. Together, these efforts are helping expand access to care, resources and support for individuals and families throughout the state. Health Starts at Home: Investing in Affordable Housing Across MassachusettsCVS Health has inve

    7/22/26 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Pet medications now available at CVS Pharmacy®

    Dog and cat owners can now fill common pet prescriptions at all CVS Pharmacy locations nationwideWOONSOCKET, R.I., July 21, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that common prescription medications for dogs and cats are now available at its approximately 9,000 CVS Pharmacy® locations nationwide. Pet owners can fill prescriptions for select pet-only medications, including antibiotics, allergy, flea and tick control, insulin, and pain relievers, at their local CVS Pharmacy, expanding access to essential pet health care. Greater flexibility in where pet prescriptions are filled helps reduce stress and delays, ensuring pets receive the medications they need conveniently w

    7/21/26 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Pharmacy® celebrates opening of first pharmacy-focused location in Houston

    Pharmacy-focused sites to open in select communities to help increase access to pharmacy careOpenings are part of ongoing commitment to serve communities and meet consumers where they are WOONSOCKET, R.I., July 17, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) today unveiled its first pharmacy-focused CVS Pharmacy® in Houston. The new pharmacy, located at 8503A Gulf Freeway in south Houston, will help bridge gaps in pharmacy care and make it easier for community members to access medications, immunizations and other health care services provided by pharmacists. Nearly 20 pharmacy-focused locations will open in select communities

    7/17/26 12:00:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

    SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

    2/13/24 5:02:40 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13G/A filed by CVS Health Corporation (Amendment)

    SC 13G/A - CVS HEALTH Corp (0000064803) (Subject)

    2/9/23 11:16:32 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Financials

    Live finance-specific insights

    View All

    CVS Health declares quarterly dividend

    WOONSOCKET, R.I., July 10, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 3, 2026, to holders of record on July 23, 2026. About CVS HealthCVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy be

    7/10/26 9:48:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health to hold second quarter 2026 earnings conference call

    WOONSOCKET, R.I., July 6, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) will hold a conference call with analysts and investors on Wednesday, August 5, 2026, at 8:00 a.m. ET to discuss second quarter 2026 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year.About CVS HealthCVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of March 31, 2026, the Company had approximately 9,000 retail pharma

    7/6/26 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    AM Best Affirms Credit Ratings of CVS Health Corporation's Aetna Inc. Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of its ultimate parent, CVS Health Corporation (CVS Health) (NYSE:CVS). (Please see below for a detailed listing of the companies.)Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of "a" (Excellent) of Allina Health and Aetna Insurance Company (Allina Health) (St. Louis Park, MN). Allina Health is a joint venture subsidiary of Ae

    6/5/26 4:35:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    Leadership Updates

    Live Leadership Updates

    View All

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Aetna 2026 Medicare Advantage plans deliver access to affordable, personalized care

    Providing access to affordable care $0 copays on Tier 1 drugs & covered vaccines at in-network pharmacies1, $0 copay for colonoscopies and mammograms at in-network providers$0 copay for annual Healthy Home Visit from a licensed Signify Health clinicianContinued investment in technology, tools and teams that support our members Commitment to supporting unique member needs — those living with chronic conditions and individuals dually eligible for both Medicare and MedicaidLeveraging the strength of the CVS Health family of companies to deliver differentiated member experiencesWOONSOCKET, R.I., Oct. 1, 2025 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), today announced our 2026 Medi

    10/1/25 7:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health Announces Chief Financial Officer Transition Plan; Appoints Chief Medical Officer

    WOONSOCKET, R.I., April 8, 2025 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced two leadership updates. Brian Newman has been named executive vice president and chief financial officer designate, effective April 21. He will succeed current chief financial officer, Tom Cowhey, who will transition to serve as a strategic advisor to president and chief executive officer David Joyner, effective May 12.Amy Compton-Phillips, M.D., is the company's new executive vice president and chief medical officer, effective May 19, also reporting to David Joyner.Based on year-to-date res

    4/8/25 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples